Related Experiment Video
Updated: Jul 28, 2026
04:28
Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
Carcinoid tumors and sarcoidosis--does a link exist?
N T Levy1, J Rubin, R A DeRemee
1Department of Internal Medicine, Mayo Clinic Rochester, Minnesota 55905, USA.
Mayo Clinic Proceedings
|February 1, 1997
Summary
This study explored the link between carcinoid tumors and sarcoidosis, finding that certain cancers occurred in patients with sarcoidosis. Further research into these disease mechanisms may clarify carcinoid tumor pathogenesis.
Area of Science:
- Oncology
- Immunology
- Pathology
Background:
- Sarcoidosis is an inflammatory disease characterized by granuloma formation.
- Carcinoid tumors are neuroendocrine neoplasms that can arise in various organs.
Observation:
- Seven cases of co-occurring sarcoidosis and carcinoid tumors were identified between 1950 and 1994.
- Patients ranged from 31 to 66 years old; three had a history of benign thyroid disorders.
- The temporal relationship between sarcoidosis and carcinoid tumors varied among cases.
Findings:
- Malignant lesions, specifically carcinoid tumors, were observed in patients with sarcoidosis.
- Hypothesized mechanisms include sarcoidosis-induced immunologic abnormalities promoting neoplasia, or malignant disease triggering sarcoidosis.
- Biopsy confirmation is crucial to differentiate metastatic disease from sarcoidosis in cases with lymphadenopathy.
Implications:
- Understanding the interplay between sarcoidosis and carcinoid tumors may elucidate the pathogenesis of neuroendocrine tumors.
- This research highlights the need for careful diagnosis in patients with co-existing conditions.
- Further investigation into shared immunologic or inflammatory pathways is warranted.
More Related Videos
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...